Skip to main content
. Author manuscript; available in PMC: 2018 May 23.
Published in final edited form as: Cancer Biol Ther. 2009 Nov 7;8(22):2136–2143. doi: 10.4161/cbt.8.22.9743

Table 1.

Tumorigenesis in NOD/SCID mice

ID Cell line Mouse NO. GSI treatment Ascites Tumor Survival time (d)
A1 BJAB 1 + + 46
A2 BJAB 2 + + 51
A3 BJAB 3 + + 56
A4 BJAB 4 + + 72
A5 BJAB 5 + + 55
A6 BJAB 6 + + 50
A7 BJAB 7 + + 71
A8 BJAB 8 + + 47
A9 BJAB 1 + + + 74
A10 BJAB 2 + + + 50
A11 BJAB 3 + + + 42
A12 BJAB 4 + + + 52
A13 BJAB 5 + + + 44
A14 BJAB 6 + + + 48
A15 BJAB 7 + + + 53
A16 BJAB 8 + + + 71
A17 1 + + 48
A18 2 + + 42
A19 3 + + 47
4 + + 42
A21 5 + + 50
6 + + 47
7 + + 48
8 + + 50
1 + + + 60
2 + + + 51
3 + + + 44
4 + + + 70
5 + + + 66
6 + + + 59
A31 7 + + + 66
8 + + + 69
JSC1 1 + + 23
JSC1 2 + + 24
JSC1 3 + + 21
JSC1 4 + + 24
JSC1 5 + + 21
JSC1 6 + + 23
JSC1 7 + + 25
JSC1 8 + + 25
A41 JSC1 1 + + + 21
A42 JSC1 2 + + + 26
A43 JSC1 3 + + + 29
JSC1 4 + + + 27
JSC1 5 + + + 23
JSC1 6 + + + 31
A47 JSC1 7 + + + 44
JSC1 8 + + + 48